CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 529041-529258
Annnotations
CORD-19-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5927 | 0-217 | Sentence | denotes | Although not recommended as a sole determinant of EGFR tyrosine kinase inhibitor (TKI) therapy, KRAS mutations have been determined as mutually exclusive with EGFR mutations and intrinsically resistant to TKI therapy. |
CORD-19_Custom_license_subset
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T284 | 0-217 | Sentence | denotes | Although not recommended as a sole determinant of EGFR tyrosine kinase inhibitor (TKI) therapy, KRAS mutations have been determined as mutually exclusive with EGFR mutations and intrinsically resistant to TKI therapy. |